ARVD and Sport
Textbook on ARVD
Research in Padua
Medical therapy with sotalol or amiodarone, or combination therapy (Class Ic
drugs plus beta-blocking drugs, or amiodarone plus beta-blocking drugs) is
frequently effective in preventing recurrent ventricular tachycardia.
Ablation using radiofrequency (RF) or direct current (DC) energy is reserved
for patients who are unresponsive or intolerant of antiarrhythmic drugs.
Ventricular arrhythmia recurrence of different morphology is not uncommon
after apparent successful ablation. There appears to be a lower rate of
successful ablation using RF energy. However, patients with this condition
who have been resuscitated from sudden cardiac death or those refractory to
medical treatment are candidates for ablation, implantation of an automatic
cardioverter defibrillator, or cardiac transplantation. Surgery consisting
of total disconnection of the right ventricle is a promising therapeutic
modality. (Marcus & Fontaine, 1995).